Sivia Capital Partners LLC Makes New $577,000 Investment in Bath & Body Works, Inc. $BBWI

Sivia Capital Partners LLC bought a new position in Bath & Body Works, Inc. (NYSE:BBWI) in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 28,715 shares of the company’s stock, valued at approximately $577,000.

A number of other large investors have also bought and sold shares of the company. Alliancebernstein L.P. increased its position in Bath & Body Works by 2.2% in the third quarter. Alliancebernstein L.P. now owns 5,861,444 shares of the company’s stock worth $150,991,000 after buying an additional 123,648 shares during the last quarter. American Century Companies Inc. increased its position in Bath & Body Works by 2,204.1% in the third quarter. American Century Companies Inc. now owns 5,174,370 shares of the company’s stock worth $133,292,000 after buying an additional 4,949,796 shares during the last quarter. AQR Capital Management LLC increased its position in Bath & Body Works by 17.1% in the third quarter. AQR Capital Management LLC now owns 4,921,968 shares of the company’s stock worth $126,790,000 after buying an additional 718,642 shares during the last quarter. Geode Capital Management LLC increased its position in Bath & Body Works by 2.9% in the fourth quarter. Geode Capital Management LLC now owns 3,960,475 shares of the company’s stock worth $79,542,000 after buying an additional 110,602 shares during the last quarter. Finally, Jupiter Asset Management Ltd. increased its position in Bath & Body Works by 553.2% in the third quarter. Jupiter Asset Management Ltd. now owns 3,714,499 shares of the company’s stock worth $95,685,000 after buying an additional 3,145,797 shares during the last quarter. 95.14% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of analysts have issued reports on BBWI shares. UBS Group decreased their target price on Bath & Body Works from $22.00 to $19.00 and set a “neutral” rating for the company in a research report on Wednesday, May 20th. Wells Fargo & Company decreased their target price on Bath & Body Works from $29.00 to $25.00 and set an “overweight” rating for the company in a research report on Thursday, May 28th. Piper Sandler initiated coverage on Bath & Body Works in a research report on Friday, May 15th. They issued a “neutral” rating and a $20.00 price target for the company. Deutsche Bank Aktiengesellschaft lifted their price target on Bath & Body Works from $21.00 to $22.00 and gave the company a “hold” rating in a research report on Tuesday, March 3rd. Finally, Citigroup cut Bath & Body Works from a “buy” rating to a “neutral” rating and lifted their price target for the company from $21.00 to $25.00 in a research report on Tuesday, February 17th. Three equities research analysts have rated the stock with a Buy rating, fourteen have issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the stock has an average rating of “Hold” and a consensus price target of $21.93.

Bath & Body Works Stock Performance

Shares of NYSE BBWI opened at $17.44 on Friday. The stock has a market cap of $3.51 billion, a PE ratio of 4.90, a price-to-earnings-growth ratio of 1.78 and a beta of 1.42. Bath & Body Works, Inc. has a fifty-two week low of $14.27 and a fifty-two week high of $33.96. The stock has a fifty day moving average of $18.58 and a 200-day moving average of $20.08.

Bath & Body Works (NYSE:BBWI) last announced its quarterly earnings results on Wednesday, May 27th. The company reported $0.32 earnings per share for the quarter, beating the consensus estimate of $0.29 by $0.03. The company had revenue of $1.38 billion during the quarter, compared to analysts’ expectations of $1.36 billion. Bath & Body Works had a negative return on equity of 45.34% and a net margin of 10.03%.The firm’s quarterly revenue was down 3.2% compared to the same quarter last year. During the same period in the previous year, the business earned $0.49 earnings per share. Bath & Body Works has set its Q2 2026 guidance at 0.300-0.300 EPS and its FY 2026 guidance at 2.400-2.650 EPS. On average, sell-side analysts predict that Bath & Body Works, Inc. will post 2.61 EPS for the current year.

Bath & Body Works Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, June 19th. Investors of record on Friday, June 5th will be paid a dividend of $0.20 per share. The ex-dividend date of this dividend is Friday, June 5th. This represents a $0.80 annualized dividend and a yield of 4.6%. Bath & Body Works’s dividend payout ratio (DPR) is currently 22.47%.

Bath & Body Works Company Profile

Bath & Body Works, Inc is a leading specialty retailer focused on personal care, home fragrance and complementary products. Through its flagship Bath & Body Works brand, the company offers a diverse assortment of shower gels, lotions, fragrance mists, candles and home fragrance items. Its product portfolio also includes the White Barn Candle Co range of premium scented candles and diffusers. Bath & Body Works serves consumers through a combination of brick-and-mortar stores and e-commerce platforms, delivering seasonal collections, limited-edition releases and signature scent lines.

Founded in 1990 as part of Limited Brands (now L Brands), Bath & Body Works opened its first store in New Albany, Ohio, and quickly expanded across the United States.